Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-42,page-paged-42,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.4.2,vc_responsive

CLIENT NEWS

 

 

  • Ergomed plc: Revenue and EBITDA for full year 2019 expected to be ahead of market expectations
    22 July 2019
    www.ergomedplc.com
  • Ergomed plc: Appointments of Rolf Soderstrom and Dr Jim Esinhart as Non-Executive Directors
    22 July 2019
    www.ergomedplc.com
  • InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa
    19 July 2019
    www.inflarx.com
  • Adocia Presents First Half 2019 Financial Results
    18 July 2019
    www.adocia.com
  • Atriva Therapeutics Receives EU Award for Biomarker Validation
    17 July 2019
    www.atriva-therapeutics.com
  • Motif Bio plc: Motif Bio Submits Meeting Request and Package to the U.S. FDA for Iclaprim
    15 July 2019
    www.motifbio.com
  • ABIVAX Completes €12 Million Capital Raise Entirely Subscribed by Sofinnova Partners at Market Price
    11 July 2019
    www.abivax.com
  • Heidelberg Pharma reports on first half-year
    11 July 2019
    www.heidelberg-pharma.com
  • Newron’s commercialization partner Zambon and Valeo Pharma announce the launch of Onstryv® (safinamide) for Parkinson’s disease in Canada
    10 July 2019
    www.newron.com
  • Expedeon AG announces Outcome of Annual General Meeting 2019
    10 July 2019
    www.expedeon.com